JNJ vs. CLS
JNJ (Johnson & Johnson) and CLS (Celestica Inc.) are both stocks. JNJ operates in Drug Manufacturers - General (Healthcare), while CLS operates in Electronic Components (Technology). Over the past 10 years, JNJ returned 10.71%/yr vs 39.15%/yr for CLS. At a 0.16 correlation, their price movements are largely independent.
Performance
JNJ vs. CLS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, JNJ achieves a 28.69% return, which is significantly higher than CLS's 3.27% return. Over the past 10 years, JNJ has underperformed CLS with an annualized return of 10.71%, while CLS has yielded a comparatively higher 39.15% annualized return.
JNJ
- 1D
- 1.59%
- 1M
- 9.29%
- 6M
- 20.98%
- YTD
- 28.69%
- 1Y
- 59.22%
- 3Y*
- 18.59%
- 5Y*
- 12.03%
- 10Y*
- 10.71%
- ALL TIME*
- 12.34%
CLS
- 1D
- -8.80%
- 1M
- -15.72%
- 6M
- 0.72%
- YTD
- 3.27%
- 1Y
- 86.17%
- 3Y*
- 164.38%
- 5Y*
- 110.65%
- 10Y*
- 39.15%
- ALL TIME*
- 13.25%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $647.00M | $614.33M | $803.67M | |
| $2.16B | $2.18B | $1.96B |
JNJ vs. CLS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
JNJ Johnson & Johnson | 28.69% | 47.48% | -4.81% | -8.58% | 5.97% | 11.44% | 10.82% | 16.22% | -5.13% | 24.43% |
CLS Celestica Inc. | 3.27% | 220.27% | 215.23% | 159.80% | 1.26% | 37.92% | -2.42% | -5.70% | -16.32% | -11.56% |
Correlation
The correlation between JNJ and CLS is -0.11, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.03 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.07 |
Correlation (All Time) Calculated using the full available price history since Jun 30, 1998 | 0.16 |
The correlation between JNJ and CLS shifts across timeframes, from -0.13 (3 years) to 0.16 (all time), reflecting how their relationship changes across market environments.
Fundamentals
JNJ:
$634.06B
CLS:
$35.10B
JNJ:
$8.63
CLS:
$8.29
JNJ:
30.53
CLS:
36.84
JNJ:
1.02
CLS:
0.49
JNJ:
6.56
CLS:
2.56
JNJ:
7.56
CLS:
16.83
JNJ:
$97.93B
CLS:
$13.81B
JNJ:
$68.99B
CLS:
$1.60B
JNJ:
$31.92B
CLS:
$1.32B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JNJ vs. CLS — Risk / Return Rank
JNJ
CLS
JNJ vs. CLS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Johnson & Johnson (JNJ) and Celestica Inc. (CLS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| JNJ | CLS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.13 | ||
| Sortino ratioReturn per unit of downside risk | +2.74 | ||
| Omega ratioGain probability vs. loss probability | 1.56 | 1.22 | +0.33 |
| Calmar ratioReturn relative to maximum drawdown | 5.43 | 2.39 | +3.04 |
| Martin ratioReturn relative to average drawdown | 15.17 | 5.79 | +9.37 |
Loading charts...
Drawdowns
JNJ vs. CLS - Drawdown Comparison
The maximum JNJ drawdown since its inception was -50.67%, smaller than the maximum CLS drawdown of -96.93%. Use the drawdown chart below to compare losses from any high point for JNJ and CLS.
Loading charts...
Drawdown Indicators
| JNJ | CLS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -50.67% | -96.93% | +46.26% |
Max Drawdown (1Y)Largest decline over 1 year | -10.96% | -36.21% | +25.25% |
Max Drawdown (3Y)Largest decline over 3 years | -15.95% | -53.96% | +38.01% |
Max Drawdown (5Y)Largest decline over 5 years | -18.41% | -53.96% | +35.55% |
Max Drawdown (10Y)Largest decline over 10 years | -27.37% | -80.60% | +53.23% |
Current DrawdownCurrent decline from peak | -1.44% | -35.38% | +33.94% |
Average DrawdownAverage peak-to-trough decline | -11.88% | -73.13% | +61.25% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.92% | 14.92% | -11.00% |
Volatility
JNJ vs. CLS - Volatility Comparison
The current volatility for Johnson & Johnson (JNJ) is 8.75%, while Celestica Inc. (CLS) has a volatility of 22.47%. This indicates that JNJ experiences smaller price fluctuations and is considered to be less risky than CLS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| JNJ | CLS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.75% | 22.47% | -13.72% |
Volatility (6M)Calculated over the trailing 6-month period | 14.62% | 56.09% | -41.47% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.12% | 75.19% | -57.07% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.37% | 58.52% | -41.15% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.71% | 50.42% | -31.71% |
Dividends
JNJ vs. CLS - Dividend Comparison
JNJ's dividend yield for the trailing twelve months is around 1.99%, while CLS has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLS Celestica Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
JNJ Johnson & Johnson | 1.99% | 2.48% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% |
Financials
JNJ vs. CLS - Financials Comparison
This section allows you to compare key financial metrics between Johnson & Johnson and Celestica Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
JNJ vs. CLS - Profitability Comparison
JNJ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Johnson & Johnson reported a gross profit of 18.50B and revenue of 25.31B. Therefore, the gross margin over that period was 73.1%.
CLS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Celestica Inc. reported a gross profit of 437.20M and revenue of 4.05B. Therefore, the gross margin over that period was 10.8%.
JNJ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Johnson & Johnson reported an operating income of 7.17B and revenue of 25.31B, resulting in an operating margin of 28.3%.
CLS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Celestica Inc. reported an operating income of 272.10M and revenue of 4.05B, resulting in an operating margin of 6.7%.
JNJ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Johnson & Johnson reported a net income of 5.53B and revenue of 25.31B, resulting in a net margin of 21.9%.
CLS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Celestica Inc. reported a net income of 212.30M and revenue of 4.05B, resulting in a net margin of 5.3%.
Frequently Asked Questions
JNJ and CLS have a correlation of -0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CLS has higher volatility (22.47%) compared to JNJ (8.75%). In terms of maximum drawdown, JNJ dropped -50.67% vs CLS's -96.93%.
JNJ currently has the higher Sharpe Ratio (3.28 vs 1.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for JNJ and CLS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer